共 13 条
[1]
Shaib YH(2004)Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 40 472-477
[2]
Davila JA(2015)Defining the benefit of adjuvant therapy following resection for intrahepatic cholangiocarcinoma Ann Surg Oncol. 22 2209-2217
[3]
McGlynn K(2010)Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med. 362 1273-1281
[4]
El-Serag HB(2014)Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial Lancet Oncol. 15 819-828
[5]
Sur MD(undefined)undefined undefined undefined undefined-undefined
[6]
In H(undefined)undefined undefined undefined undefined-undefined
[7]
Sharpe SM(undefined)undefined undefined undefined undefined-undefined
[8]
Valle J(undefined)undefined undefined undefined undefined-undefined
[9]
Wasan H(undefined)undefined undefined undefined undefined-undefined
[10]
Palmer DH(undefined)undefined undefined undefined undefined-undefined